2021 Q1 Form 10-Q Financial Statement

#000143774921005158 Filed on March 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1 2018
Revenue $574.7M $494.1M $1.991B
YoY Change 16.32% 29.81% -18.78%
Cost Of Revenue $458.7M $417.3M $1.631B
YoY Change 9.92% 32.1% -21.15%
Gross Profit $116.0M $76.70M $360.5M
YoY Change 51.24% 18.55% -6.0%
Gross Profit Margin 20.19% 15.52% 18.1%
Selling, General & Admin $63.70M $60.40M $228.8M
YoY Change 5.46% 0.0% -10.52%
% of Gross Profit 54.91% 78.75% 63.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.338M $1.279M $3.156M
YoY Change 4.61% 30.64% -25.72%
% of Gross Profit 1.15% 1.67% 0.88%
Operating Expenses $64.00M $60.70M $230.5M
YoY Change 5.44% 0.17% -10.35%
Operating Profit $52.00M $16.00M $130.0M
YoY Change 225.0% 290.24% 2.85%
Interest Expense -$32.40M -$33.00M $164.1M
YoY Change -1.82% 55.66% -11.41%
% of Operating Profit -62.31% -206.25% 126.22%
Other Income/Expense, Net
YoY Change
Pretax Income $19.59M -$7.436M $8.100M
YoY Change -363.38% -56.53% -117.9%
Income Tax $600.0K $1.712M $3.600M
% Of Pretax Income 3.06% 44.44%
Net Earnings $18.96M -$9.148M $4.520M
YoY Change -307.25% -47.58% -101.36%
Net Earnings / Revenue 3.3% -1.85% 0.23%
Basic Earnings Per Share $2.79 -$1.49 $0.73
Diluted Earnings Per Share $2.75 -$1.49 $0.72
COMMON SHARES
Basic Shares Outstanding 6.225K 6.160M 5.941M
Diluted Shares Outstanding 6.303K 6.160M 6.072M

Balance Sheet

Concept 2021 Q1 2020 Q1 2018
SHORT-TERM ASSETS
Cash & Short-Term Investments $172.1M $81.40M $187.9M
YoY Change 111.43% -28.16% -59.48%
Cash & Equivalents $226.7M $127.9M $187.9M
Short-Term Investments
Other Short-Term Assets $41.00M $71.30M $39.20M
YoY Change -42.5% 66.2% 5.95%
Inventory $1.281B $1.296B $1.078B
Prepaid Expenses
Receivables $41.20M $49.20M $35.20M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.535B $1.498B $1.341B
YoY Change 2.52% 9.53% -14.54%
LONG-TERM ASSETS
Property, Plant & Equipment $37.40M $19.70M $20.30M
YoY Change 89.85% -2.96% -61.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $93.50M $135.3M $123.7M
YoY Change -30.89% 4.97% 7.47%
Other Assets $12.60M $19.90M $12.80M
YoY Change -36.68% 55.47% 509.52%
Total Long-Term Assets $315.3M $292.4M $321.5M
YoY Change 7.83% 14.03% -3.25%
TOTAL ASSETS
Total Short-Term Assets $1.535B $1.498B $1.341B
Total Long-Term Assets $315.3M $292.4M $321.5M
Total Assets $1.851B $1.790B $1.662B
YoY Change 3.39% 10.24% -12.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $149.1M $136.9M $127.8M
YoY Change 8.91% 17.61% -0.78%
Accrued Expenses $113.7M $95.20M $68.10M
YoY Change 19.43% 155.23% 13.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $324.5M $269.4M $229.3M
YoY Change 20.45% 43.37% 1.96%
LONG-TERM LIABILITIES
Long-Term Debt $1.558B $1.666B $1.570B
YoY Change -6.51% 1.77% -10.63%
Other Long-Term Liabilities $385.0M $353.7M $315.9M
YoY Change 8.85% 31.34% -16.67%
Total Long-Term Liabilities $1.943B $2.020B $1.886B
YoY Change -3.82% 5.95% -11.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $324.5M $269.4M $229.3M
Total Long-Term Liabilities $1.943B $2.020B $1.886B
Total Liabilities $2.267B $2.289B $2.116B
YoY Change -0.96% 9.31% -10.41%
SHAREHOLDERS EQUITY
Retained Earnings -$1.156B -$1.235B
YoY Change -6.4% 2.81%
Common Stock $718.8M $715.3M
YoY Change 0.49% 0.84%
Preferred Stock
YoY Change
Treasury Stock (at cost) $115.4M $115.4M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity -$417.2M -$499.8M -$453.5M
YoY Change
Total Liabilities & Shareholders Equity $1.851B $1.790B $1.662B
YoY Change 3.39% 10.24% -12.57%

Cashflow Statement

Concept 2021 Q1 2020 Q1 2018
OPERATING ACTIVITIES
Net Income $18.96M -$9.148M $4.520M
YoY Change -307.25% -47.58% -101.36%
Depreciation, Depletion And Amortization $1.338M $1.279M $3.156M
YoY Change 4.61% 30.64% -25.72%
Cash From Operating Activities -$94.06M $27.64M -$66.82M
YoY Change -440.25% -122.63% -122.16%
INVESTING ACTIVITIES
Capital Expenditures $964.0K $809.0K $5.193M
YoY Change 19.16% -20.61% -19.84%
Acquisitions
YoY Change
Other Investing Activities $8.800M -$16.00M $40.70M
YoY Change -155.0% -463.64% -275.43%
Cash From Investing Activities $7.873M -$16.80M $35.50M
YoY Change -146.85% -595.08% -219.5%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $3.433M -$65.16M -$229.4M
YoY Change -105.27% -267.25% 55.18%
NET CHANGE
Cash From Operating Activities -$94.06M $27.64M -$66.82M
Cash From Investing Activities $7.873M -$16.80M $35.50M
Cash From Financing Activities $3.433M -$65.16M -$229.4M
Net Change In Cash -$82.75M -$54.32M -$260.8M
YoY Change 52.35% -31.95% -310.23%
FREE CASH FLOW
Cash From Operating Activities -$94.06M $27.64M -$66.82M
Capital Expenditures $964.0K $809.0K $5.193M
Free Cash Flow -$95.02M $26.84M -$72.02M
YoY Change -454.1% -121.78% -124.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5600
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5600
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5600
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5600
CY2021Q1 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
140000000 USD
CY2020Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
140000000 USD
CY2020Q4 hov General Liability Insurance Deductible
GeneralLiabilityInsuranceDeductible
20000000 USD
CY2020Q4 hov Bodily Injury Insurance Deductible
BodilyInjuryInsuranceDeductible
250000 USD
CY2020Q4 hov Bodily Injury Insurance Limit
BodilyInjuryInsuranceLimit
5000000 USD
CY2021Q1 hov Aggregate Retention For Construction Defects Warranty And Bodily Injury Claims
AggregateRetentionForConstructionDefectsWarrantyAndBodilyInjuryClaims
20000000 USD
CY2020Q4 hov Aggregate Retention For Construction Defects Warranty And Bodily Injury Claims
AggregateRetentionForConstructionDefectsWarrantyAndBodilyInjuryClaims
20000000 USD
CY2020Q1 hov Payments By Insurance Companies For Claims
PaymentsByInsuranceCompaniesForClaims
100000 USD
CY2021Q1 hov Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
1700000 USD
CY2021Q1 hov Conversion Of Stock From Class B To Class A Conversion Ratio
ConversionOfStockFromClassBToClassAConversionRatio
1 pure
CY2020Q1 hov Number Of Owned Communities Transferred To The Joint Venture
NumberOfOwnedCommunitiesTransferredToTheJointVenture
8 pure
CY2020Q1 hov Number Of Owned Active Communities Transferred To The Joint Venture
NumberOfOwnedActiveCommunitiesTransferredToTheJointVenture
4 pure
CY2021Q1 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 USD
CY2020Q1 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 USD
CY2021Q1 us-gaap Assets
Assets
1850699000 USD
CY2020Q4 us-gaap Assets
Assets
1827342000 USD
CY2021Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
4389000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
2267034000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
2263436000 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
135299000 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
135299000 USD
CY2021Q1 hov Real Estate Inventory Expense Not Eligible For Capitalization
RealEstateInventoryExpenseNotEligibleForCapitalization
23975000 USD
CY2020Q1 hov Real Estate Inventory Expense Not Eligible For Capitalization
RealEstateInventoryExpenseNotEligibleForCapitalization
25003000 USD
CY2020Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
3832000 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
718832000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
718110000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1156086000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1175045000 USD
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
115360000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
115360000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-417248000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-436929000 USD
CY2021Q1 us-gaap Minority Interest
MinorityInterest
913000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
835000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-416335000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-436094000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1850699000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1827342000 USD
CY2021Q1 us-gaap Revenues
Revenues
574664000 USD
CY2020Q1 us-gaap Revenues
Revenues
494056000 USD
CY2021Q1 hov Corporate General And Administrative
CorporateGeneralAndAdministrative
23483000 USD
CY2020Q1 hov Corporate General And Administrative
CorporateGeneralAndAdministrative
19744000 USD
CY2021Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-278000 USD
CY2020Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-194000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
556995000 USD
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
512488000 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
9456000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1916000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1540000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19585000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7436000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
626000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1712000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
18959000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-9148000 USD
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
2.79
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.49
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6225000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6161000
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.75
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.49
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6303000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6161000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-436094000 USD
CY2021Q1 hov Stock Options Amortization And Issuance Value
StockOptionsAmortizationAndIssuanceValue
54000 USD
CY2021Q1 hov Stock Issued During Period Value Restricted Stock Awards Net Of Forfeitures And Adjustments To Additional Paid In Capital Share Based Compensation Requisite Service Period Recognition Value
StockIssuedDuringPeriodValueRestrictedStockAwardsNetOfForfeituresAndAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionValue
668000 USD
CY2021Q1 hov Conversion Of Stock Value
ConversionOfStockValue
0 USD
CY2021Q1 hov Changes In Noncontrolling Interest In Consolidated Joint Ventures
ChangesInNoncontrollingInterestInConsolidatedJointVentures
78000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
18959000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-489776000 USD
CY2020Q1 hov Stock Options Amortization And Issuance Value
StockOptionsAmortizationAndIssuanceValue
162000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-416335000 USD
CY2021Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
334272000 USD
CY2020Q1 hov Changes In Noncontrolling Interest In Consolidated Joint Ventures
ChangesInNoncontrollingInterestInConsolidatedJointVentures
13000 USD
CY2020Q1 hov Stock Issued During Period Value Restricted Stock Awards Net Of Forfeitures And Adjustments To Additional Paid In Capital Share Based Compensation Requisite Service Period Recognition Value
StockIssuedDuringPeriodValueRestrictedStockAwardsNetOfForfeituresAndAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionValue
-330000 USD
CY2020Q1 hov Conversion Of Stock Value
ConversionOfStockValue
0 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 USD
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
9456000 USD
CY2021Q1 hov Noncontrolling Interest Income In Consolidated Joint Venture
NoncontrollingInterestIncomeInConsolidatedJointVenture
-78000 USD
CY2020Q1 hov Noncontrolling Interest Income In Consolidated Joint Venture
NoncontrollingInterestIncomeInConsolidatedJointVenture
-13000 USD
CY2021Q1 hov Inventory Impairments And Land Option Cost Write Offs
InventoryImpairmentsAndLandOptionCostWriteOffs
1877000 USD
CY2020Q1 hov Inventory Impairments And Land Option Cost Write Offs
InventoryImpairmentsAndLandOptionCostWriteOffs
2828000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-9148000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-499079000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
18959000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-9148000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
1338000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
1279000 USD
CY2021Q1 hov Sharebased Payment Arrangement Noncash Expense Income Total
SharebasedPaymentArrangementNoncashExpenseIncomeTotal
902000 USD
CY2020Q1 hov Sharebased Payment Arrangement Noncash Expense Income Total
SharebasedPaymentArrangementNoncashExpenseIncomeTotal
-116000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
209000 USD
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1281000 USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
14000 USD
CY2020Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
2000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1916000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1540000 USD
CY2021Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2841000 USD
CY2020Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
9250000 USD
CY2020Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
268465000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
312794000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
345183000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
9531000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4437000 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
87251000 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6058000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
557000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1714000 USD
CY2021Q1 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
8975000 USD
CY2020Q1 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-2560000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9605000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-32122000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-94059000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27644000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
16000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
9000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
964000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
809000 USD
CY2021Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
3214000 USD
CY2020Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
18524000 USD
CY2021Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
12035000 USD
CY2020Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
2521000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7873000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16803000 USD
CY2021Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
64257000 USD
CY2020Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
60437000 USD
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
72235000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-54318000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
309460000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
182266000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
226707000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
127948000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
9922000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
13955000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
69000 USD
CY2020Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
58725000 USD
CY2021Q1 hov Proceeds From Model Sale Leaseback Financing Programs
ProceedsFromModelSaleLeasebackFinancingPrograms
1360000 USD
CY2020Q1 hov Proceeds From Model Sale Leaseback Financing Programs
ProceedsFromModelSaleLeasebackFinancingPrograms
2368000 USD
CY2021Q1 hov Payments For Model Sale Leaseback Financing Programs
PaymentsForModelSaleLeasebackFinancingPrograms
3583000 USD
CY2020Q1 hov Payments For Model Sale Leaseback Financing Programs
PaymentsForModelSaleLeasebackFinancingPrograms
7474000 USD
CY2021Q1 hov Proceeds From Land Bank Financing Program
ProceedsFromLandBankFinancingProgram
15025000 USD
CY2020Q1 hov Proceeds From Land Bank Financing Program
ProceedsFromLandBankFinancingProgram
39620000 USD
CY2021Q1 hov Payments For Land Bank Financing Program
PaymentsForLandBankFinancingProgram
24726000 USD
CY2020Q1 hov Payments For Land Bank Financing Program
PaymentsForLandBankFinancingProgram
23544000 USD
CY2021Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
23925000 USD
CY2020Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-67204000 USD
CY2021Q1 hov Payment Of Financing Costs For Debt Issuance And Land Bank Financing
PaymentOfFinancingCostsForDebtIssuanceAndLandBankFinancing
590000 USD
CY2020Q1 hov Payment Of Financing Costs For Debt Issuance And Land Bank Financing
PaymentOfFinancingCostsForDebtIssuanceAndLandBankFinancing
10637000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3433000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-65159000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-82753000 USD
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-2000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
226707000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
127948000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
900000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
800000 USD
CY2020Q1 hov Allocated Share Based Compensation Income
AllocatedShareBasedCompensationIncome
100000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
600000 USD
CY2020Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
65010000 USD
CY2019Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
71264000 USD
CY2021Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
41457000 USD
CY2020Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
44334000 USD
CY2021Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
17165000 USD
CY2020Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
18136000 USD
CY2021Q1 hov Real Estate Inventory Expense Not Eligible For Capitalization
RealEstateInventoryExpenseNotEligibleForCapitalization
23975000 USD
CY2020Q1 hov Real Estate Inventory Expense Not Eligible For Capitalization
RealEstateInventoryExpenseNotEligibleForCapitalization
25003000 USD
CY2021Q1 hov Real Estate Inventory Capitalized Interest Costs Interest Contributed To Joint Venture
RealEstateInventoryCapitalizedInterestCostsInterestContributedToJointVenture
0 USD
CY2020Q1 hov Real Estate Inventory Capitalized Interest Costs Interest Contributed To Joint Venture
RealEstateInventoryCapitalizedInterestCostsInterestContributedToJointVenture
4580000 USD
CY2021Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
65327000 USD
CY2020Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
67879000 USD
CY2021Q1 hov Real Estate Inventory Expense Not Eligible For Capitalization
RealEstateInventoryExpenseNotEligibleForCapitalization
23975000 USD
CY2020Q1 hov Real Estate Inventory Expense Not Eligible For Capitalization
RealEstateInventoryExpenseNotEligibleForCapitalization
25003000 USD
CY2021Q1 us-gaap Interest Paid
InterestPaid
425000 USD
CY2020Q1 us-gaap Interest Paid
InterestPaid
770000 USD
CY2021Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
14478000 USD
CY2020Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
11818000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
9922000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
13955000 USD
CY2021Q1 hov Deposits Associated With Land And Lot Options Of Unconsolidated Variable Interest Entities
DepositsAssociatedWithLandAndLotOptionsOfUnconsolidatedVariableInterestEntities
90800000 USD
CY2021Q1 hov Purchase Price Associated With Land And Lot Options Of Unconsolidated Variable Interest Entities
PurchasePriceAssociatedWithLandAndLotOptionsOfUnconsolidatedVariableInterestEntities
1200000000 USD
CY2021Q1 hov Cash Received From Subcontractors For Owner Controlled Insurance Program
CashReceivedFromSubcontractorsForOwnerControlledInsuranceProgram
1500000 USD
CY2020Q1 hov Cash Received From Subcontractors For Owner Controlled Insurance Program
CashReceivedFromSubcontractorsForOwnerControlledInsuranceProgram
1300000 USD
CY2021Q1 hov General Liability Insurance Deductible
GeneralLiabilityInsuranceDeductible
20000000 USD
CY2021Q1 hov Bodily Injury Insurance Deductible
BodilyInjuryInsuranceDeductible
250000 USD
CY2021Q1 hov Bodily Injury Insurance Limit
BodilyInjuryInsuranceLimit
5000000 USD
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
86417000 USD
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
89371000 USD
CY2021Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1976000 USD
CY2020Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3665000 USD
CY2021Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
474000 USD
CY2020Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
355000 USD
CY2021Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
88861000 USD
CY2020Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
89905000 USD
CY2021Q1 hov Payments By Insurance Companies For Claims
PaymentsByInsuranceCompaniesForClaims
100000 USD
CY2020Q4 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
1458000 USD
CY2019Q4 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
1268000 USD
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
50000 USD
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
40000 USD
CY2021Q1 us-gaap Allowance For Loan And Lease Losses Adjustments Net
AllowanceForLoanAndLeaseLossesAdjustmentsNet
0 USD
CY2020Q1 us-gaap Allowance For Loan And Lease Losses Adjustments Net
AllowanceForLoanAndLeaseLossesAdjustmentsNet
0 USD
CY2021Q1 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
1508000 USD
CY2020Q1 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
1308000 USD
CY2021Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
13200000 USD
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
15500000 USD
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
2616000 USD
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
2591000 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2298000 USD
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2316000 USD
CY2021Q1 hov Increase Decrease In Operating Lease Rightofuse Asset
IncreaseDecreaseInOperatingLeaseRightofuseAsset
1700000 USD
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.095 pure
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.096 pure
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
6814000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7876000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4737000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2015000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1632000 USD
CY2021Q1 hov Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
1162000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
24236000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3572000 USD
CY2021Q1 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
111900000 USD
CY2020Q4 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
87900000 USD
CY2021Q1 hov Number Of Loans Reserved For
NumberOfLoansReservedFor
15 pure
CY2020Q1 hov Number Of Loans Reserved For
NumberOfLoansReservedFor
21 pure
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1435749000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1435749000 USD
CY2021Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
15563000 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
17521000 USD
CY2021Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
21099000 USD
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
22160000 USD
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
1430213000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
1431110000 USD
CY2021Q1 hov Debt Covenant Fixed Charge Coverage Ratio Minimum
DebtCovenantFixedChargeCoverageRatioMinimum
2.0 pure
CY2021Q1 hov Secured Debt Leverage Ratio
SecuredDebtLeverageRatio
4.0 pure
CY2021Q1 hov Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
17360000 USD
CY2020Q1 hov Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-9148000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6225000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6160000
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
78000
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6303000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6160000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.79
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.49
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.75
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.49
CY2021Q1 hov Common Stock Dividends Percent Of Increase From Class A To Class B
CommonStockDividendsPercentOfIncreaseFromClassAToClassB
1.10 pure
CY2018Q1 hov Shareholder Ownership Percentage Of Increase
ShareholderOwnershipPercentageOfIncrease
0.50 pure
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
571500000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23800000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8100000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39700000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
55400000 USD
CY2020Q3 hov Contract Pace Per Average Active Selling Community
ContractPacePerAverageActiveSellingCommunity
17.8 pure
CY2020Q4 hov Contract Pace Per Average Active Selling Community
ContractPacePerAverageActiveSellingCommunity
16.4 pure
CY2021Q1 hov Contract Pace Per Average Active Selling Community
ContractPacePerAverageActiveSellingCommunity
16.0 pure
CY2021 hov Increase Decrease In Dollar Value Of Backlog Percentage
IncreaseDecreaseInDollarValueOfBacklogPercentage
0.852 pure
CY2021Q1 us-gaap Revenues
Revenues
574664000 USD
CY2020Q1 us-gaap Revenues
Revenues
494056000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19585000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7436000 USD
CY2021Q1 us-gaap Assets
Assets
1850699000 USD
CY2020Q4 us-gaap Assets
Assets
1827342000 USD
CY2020Q1 hov Proceeds From Transfer Of Land To Joint Venture
ProceedsFromTransferOfLandToJointVenture
29800000 USD
CY2021Q1 hov Joint Venture Total Debt To Capitalization Ratio
JointVentureTotalDebtToCapitalizationRatio
0.35 pure
CY2021Q1 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><tbody><tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; vertical-align: top;"><td style="width: 18pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b><em style="font: inherit;">19.</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>Recent Accounting Pronouncements</b></p> </td></tr> </tbody></table> <p style="margin: 0pt 22.4pt 0pt 14.7pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </p> <p style="margin: 0pt; text-align: left; text-indent: 45pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">In <em style="font: inherit;"> August 2018, </em>the FASB issued ASU <em style="font: inherit;">No.</em> <em style="font: inherit;">2018</em>-<em style="font: inherit;">13,</em> “Fair Value Measurement (Topic <em style="font: inherit;">820</em>) - Disclosure Framework” (“ASU <em style="font: inherit;">2018</em>-<em style="font: inherit;">13”</em>), which improves the disclosure requirements for fair value measurements. ASU <em style="font: inherit;">2018</em>-<em style="font: inherit;">13</em> was effective for us <em style="font: inherit;"> November </em><em style="font: inherit;">1,</em> <em style="font: inherit;">2020,</em> and the adoption did <em style="font: inherit;">not</em> have a material impact on our Condensed Consolidated Financial Statements.</p> <p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </p> <p style="margin: 0pt; text-align: left; text-indent: 45pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">In <em style="font: inherit;"> August 2018, </em>the FASB issued ASU <em style="font: inherit;">No.</em> <em style="font: inherit;">2018</em>-<em style="font: inherit;">15</em> “Intangibles-Goodwill and Other-Internal-Use Software (Subtopic <em style="font: inherit;">350</em>-<em style="font: inherit;">40</em>): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract” (“ASU <em style="font: inherit;">2018</em>-<em style="font: inherit;">15”</em>). ASU <em style="font: inherit;">2018</em>-<em style="font: inherit;">15</em> aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. ASU <em style="font: inherit;">2018</em>-<em style="font: inherit;">15</em> was effective for us <em style="font: inherit;"> November 1, 2020, </em>and the adoption did <em style="font: inherit;">not</em> have a material impact on our Condensed Consolidated Financial Statements.</p> <p style="margin: 0pt; text-align: left; text-indent: 45pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </p> <p style="margin: 0pt; text-align: left; text-indent: 45pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">In <em style="font: inherit;"> March 2020, </em>the FASB issued ASU <em style="font: inherit;">2020</em>-<em style="font: inherit;">04,</em> “Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU <em style="font: inherit;">2020</em>-<em style="font: inherit;">04”</em>). ASU <em style="font: inherit;">2020</em>-<em style="font: inherit;">04</em> provides companies with optional guidance to ease the potential accounting burden associated with reference rate reform on financial reporting. This guidance became effective for the Company beginning on <em style="font: inherit;"> March 12, 2020, </em>and we <em style="font: inherit;"> may </em>elect to apply the amendments prospectively from now through <em style="font: inherit;"> December 31, 2022. </em>The Company has <em style="font: inherit;">not</em> yet adopted this guidance and is currently evaluating the potential impact of adoption on our Condensed Consolidated Financial Statements.</p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </p>
CY2021Q1 hov Loans Held For Sale Mortgages Unpaid Principal
LoansHeldForSaleMortgagesUnpaidPrincipal
121000000.0 USD
CY2020Q4 hov Loans Held For Sale Mortgages Unpaid Principal
LoansHeldForSaleMortgagesUnpaidPrincipal
100400000 USD
CY2021Q1 us-gaap Other Commitment
OtherCommitment
20000000.0 USD
CY2021Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
1301155000 USD
CY2020Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
1241570000 USD

Files In Submission

Name View Source Status
0001437749-21-005158-index-headers.html Edgar Link pending
0001437749-21-005158-index.html Edgar Link pending
0001437749-21-005158.txt Edgar Link pending
0001437749-21-005158-xbrl.zip Edgar Link pending
ex_221074.htm Edgar Link pending
ex_221075.htm Edgar Link pending
ex_221076.htm Edgar Link pending
ex_221077.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hov-20210131.xsd Edgar Link pending
hov-20210131_cal.xml Edgar Link unprocessable
hov-20210131_def.xml Edgar Link unprocessable
hov-20210131_lab.xml Edgar Link unprocessable
hov-20210131_pre.xml Edgar Link unprocessable
hov20210114_10q.htm Edgar Link pending
hov20210114_10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending